SCOPE Summit

Greenphire: Exostar partnership offers 'extreme benefit' to sites

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/BernardaSv)
(Image: iStock/BernardaSv)

Related tags: Life

Greenphire is now offering Single Sign-On (SSO) through Exostar’s identity and access management platform.

Through its partnership with Exostar, which the company announced at the SCOPE Summit last week in Miami, Florida, Greenphire’s eClinicalGPS is now available with valid credentials throughout the TransCelerate SIP and Exostar life sciences communities.

The TransCelerate Shared Investigator Platform (SIP) was developed as a single point of access for Investigator Sites and clinical trial sponsors.

Wayne Baker, Greenphire Chief Commercial Officer, told us, “The Exostar partnership and the site investigator portal offer an extreme benefit to sites​," adding that it allows the company to deliver its solution to sites in a more “seamless fashion​.”

Kenny Kong, Exostar’s Director of Life Sciences and Health IT, explained the next steps are to “continue to grow the list of eClinical partners, [and] application providers … to expand on that end user experience​.”

As we continue to grow, it’s like a mall with a lot of stores … you walk through one door and can access any retailor you want​,” he said.

Related news

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars